NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Alida Biosciences

Alida Biosciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.alidabio.com/

Last Round

Series A

Jun 12, 2024

Total Funding Raised

$19.02M

Company Overview

Alida Biosciences is a biotechnology company that develops innovative RNA biology technologies and tools to enhance human health by facilitating the discovery of new drugs and therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

epitranscriptomicsRNA modification analysisRNA sequencingNGSnext-generation sequencingRNA therapeuticsdrug discoverybioinformaticsprecision medicinebiotech reagentsassay kitsRNA profilingmolecular biology toolsepigenetics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alida Biosciences Comps

Public and private peers based on sector, stage, and business model.

Alida Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alida Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 12, 2024
GrantJun 12, 2024
GrantMay 1, 2023
GrantSep 1, 2021

Key People

Founding team and executive leadership

Gudrun Stengel

CEO Co-Founder

Founding Team

Alida Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Partnered with Storm Therapeutics to develop cancer therapies.

  • Dec 4, 2025

    Launched EpiPlex Duo-Mod Service for concurrent m6A and inosine mapping.

Alida Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alida Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alida Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range18
Year Founded2020
Last FundingJun 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.